Question 1

What are the potential benefits of participating in this trial compared to my current treatment?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the LFF269 Compared to Placebo After Treatment in Subjects With Essential Hypertension clinical trial (NCT01373086). Contact the study team or your healthcare provider for specific answers.

Question 2

What side effects should I expect from LFF269?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the LFF269 Compared to Placebo After Treatment in Subjects With Essential Hypertension clinical trial (NCT01373086). Contact the study team or your healthcare provider for specific answers.

Question 3

How will my blood pressure be monitored during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the LFF269 Compared to Placebo After Treatment in Subjects With Essential Hypertension clinical trial (NCT01373086). Contact the study team or your healthcare provider for specific answers.

Question 4

What happens if I experience side effects or my condition worsens?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the LFF269 Compared to Placebo After Treatment in Subjects With Essential Hypertension clinical trial (NCT01373086). Contact the study team or your healthcare provider for specific answers.

Question 5

Are there any costs associated with participating in this trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the LFF269 Compared to Placebo After Treatment in Subjects With Essential Hypertension clinical trial (NCT01373086). Contact the study team or your healthcare provider for specific answers.

Question 6

How long will I need to participate, and how often will I need to visit the clinic?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the LFF269 Compared to Placebo After Treatment in Subjects With Essential Hypertension clinical trial (NCT01373086). Contact the study team or your healthcare provider for specific answers.

What this study is about